Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dorr, RT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lambert, JD; Meyers, RO; Timmermann, BN; Dorr, RT
      Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse

      JOURNAL OF CHROMATOGRAPHY B
    2. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    3. Dorr, RT; Liddil, JD; Sami, SM; Remers, W; Hersh, EM; Alberts, DS
      Preclinical antitumor activity of the azonafide series of anthracene-basedDNA intercalators

      ANTI-CANCER DRUGS
    4. Taylor, CW; Dorr, RT; Fanta, P; Hersh, EM; Salmon, SE
      A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugatedL-asparaginase in patients with advanced solid tumors

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Baker, AF; Dorr, RT
      Drug interactions with the taxanes: clinical implications

      CANCER TREATMENT REVIEWS
    6. Lambert, JD; Meyers, RO; Timmermann, BN; Dorr, RT
      tetra-O-Methylnordihydroguaiaretic acid inhibits melanoma in vivo

      CANCER LETTERS
    7. Skibo, EB; Xing, CG; Dorr, RT
      Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles: Structure-activity relationships for cytotoxicity and antitumor activity

      JOURNAL OF MEDICINAL CHEMISTRY
    8. Dvorakova, K; Waltmire, CN; Payne, CM; Tome, ME; Briehl, MM; Dorr, RT
      Induction of mitochondrial changes in myeloma cells by imexon

      BLOOD
    9. Zhou, Q; Duan, WH; Simmons, D; Shayo, Y; Raymond, MA; Dorr, RT; Hurley, LH
      Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    10. Alberts, DS; Dorr, RT; Einspahr, JG; Aickin, M; Saboda, K; Xu, MJ; Peng, YM; Goldman, R; Foote, JA; Warneke, JA; Salasche, S; Roe, DJ; Bowden, GT
      Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    11. Stratton, SP; Dorr, RT; Alberts, DS
      The state-of-the-art in chemoprevention of skin cancer

      EUROPEAN JOURNAL OF CANCER
    12. Monsky, WL; Heddens, DK; Clark, GM; Von Hoff, DD; Coltman, CA; Dorr, RT; Alberts, DS
      Comparison of young clinical investigators' accuracy and reproducibility when measuring pulmonary and skin surface nodules using a circumferential measurement versus a standard caliper measurement: American Association for Cancer Research/American Society of Clinical Oncology Clinical Trials Workshop

      JOURNAL OF CLINICAL ONCOLOGY
    13. Bhardwaj, R; Hadley, ME; Dorr, RT; Dvorakova, K; Brooks, C; Blanchard, J
      Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, melanotan-I

      PHARMACEUTICAL RESEARCH
    14. Stratton, SP; Bangert, JL; Alberts, DS; Dorr, RT
      Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice

      CANCER LETTERS
    15. Dorr, RT; Dvorakova, K; Brooks, C; Lines, R; Levine, N; Schram, K; Miketova, P; Hruby, V; Alberts, DS
      Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle(4)-D-Phe(7)]-alpha-MSH in humans

      PHOTOCHEMISTRY AND PHOTOBIOLOGY
    16. Xing, CG; Wu, P; Skibo, EB; Dorr, RT
      Design of cancer-specific antitumor agents based on aziridlinylcyclopent[b]indoloquinones

      JOURNAL OF MEDICINAL CHEMISTRY
    17. Sami, SM; Dorr, RT; Alberts, DS; Solyom, AM; Remers, WA
      Analogues of amonafide and azonafide with novel ring systems

      JOURNAL OF MEDICINAL CHEMISTRY
    18. Dvorakova, K; Payne, CM; Tome, ME; Briehl, MM; McClure, T; Dorr, RT
      Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon

      BIOCHEMICAL PHARMACOLOGY
    19. Mayr, CA; Sami, SM; Remers, WA; Dorr, RT
      Intracellular localization of 6- and 7-substituted 2-[2 '-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-diones (azonafides) is not the limiting factor for their cytotoxicity: an in vitro confocal microscopy study

      ANTI-CANCER DRUGS
    20. Levine, N; Dorr, RT; Ertl, GA; Brooks, C; Alberts, DS
      Effects of a potent synthetic melanotropin, Nle(4)-D-Phe(7)-alpha-MSH (Melanotan-1) on tanning: a dose-ranging study

      JOURNAL OF DERMATOLOGICAL TREATMENT
    21. Lopez, AM; Wallace, L; Dorr, RT; Koff, M; Hersh, EM; Alberts, DS
      Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    22. Dvorakova, K; Dorr, RT; Valcic, S; Timmermann, B; Alberts, DS
      Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    23. Dorr, RT; Holmes, BC
      Dosing considerations with amifostine: A review of the literature and clinical experience

      SEMINARS IN ONCOLOGY
    24. Iyengar, BS; Dorr, RT; Alberts, DS; Hersh, EM; Salmon, SE; Remers, WA
      Novel antitumor 2-cyanoaziridine-1-carboxamides

      JOURNAL OF MEDICINAL CHEMISTRY
    25. Dorr, RT
      Managing extravasations of vesicant chemotherapy drugs

      ANTICANCER DRUG TOXICITY
    26. DORR RT
      RADIOPROTECTANTS - PHARMACOLOGY AND CLINICAL-APPLICATIONS OF AMIFOSTINE

      Seminars in radiation oncology
    27. DORR RT; MEYERS R; SNEAD K; LIDDIL JD
      ANALYTICAL AND BIOLOGICAL INEQUIVALENCE OF 2 COMMERCIAL FORMULATIONS OF THE ANTITUMOR AGENT BLEOMYCIN

      Cancer chemotherapy and pharmacology
    28. DORR RT; BELLAMY W; LIDDIL JD; BAKER A; BAIR KW
      CORRELATION OF CYTOTOXICITY AND PROTEIN-ASSOCIATED DNA STRAND BREAKS FOR 2-(ARYLMETHYLAMINO)-1,3-PROPANEDIOLS

      Anti-cancer drug design (Print)
    29. MAYR CA; SAMI SM; REMERS WA; DORR RT
      IDENTIFICATION AND CHARACTERIZATION OF IN-VITRO METABOLITES OF -1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONE (AZONAFIDE)

      Drug metabolism and disposition
    30. DVORAKOVA K; DORR RT; GALLEGOS A; MCCLURE T; POWIS G
      PHARMACOKINETIC STUDIES OF THE HERBICIDE AND ANTITUMOR COMPOUND ORYZALIN IN MICE

      Journal of chromatography B. Biomedical sciences and applications
    31. DORR RT
      CLINICAL-PHARMACOLOGY OF TAXANES AS RADIOSENSITIZERS AND THE THIOL-BASED RADIOPROTECTANT AMIFOSTINE

      Seminars in radiation oncology
    32. MAYR CA; SAMI SM; DORR RT
      IN-VITRO CYTOTOXICITY AND DNA-DAMAGE PRODUCTION IN CHINESE-HAMSTER OVARY CELLS AND TOPOISOMERASE-II INHIBITION BY 1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUTIONS AT THE 6-POSITION AND 7-POSITION (AZONAFIDES)

      Anti-cancer drugs
    33. PAINEMURRIETA GD; TAYLOR CW; CURTIS RA; LOPEZ MHA; DORR RT; JOHNSON CS; FUNK CY; THOMPSON F; HERSH EM
      HUMAN TUMOR-MODELS IN THE SEVERE COMBINED IMMUNE-DEFICIENT (SCID) MOUSE

      Cancer chemotherapy and pharmacology
    34. DORR RT
      PHARMACOLOGY OF THE TAXANES

      Pharmacotherapy
    35. TAYLOR CW; DALTON WS; MOSLEY K; DORR RT; SALMON SE
      COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN, AND DEXAMETHASONE (CVAD) PLUS ORAL QUININE AND VERAPAMIL IN PATIENTS WITH ADVANCED BREAST-CANCER

      Breast cancer research and treatment
    36. UGWU SO; BLANCHARD J; DORR RT; LEVINE N; BROOKS C; HADLEY ME; AICKIN M; HRUBY VJ
      SKIN PIGMENTATION AND PHARMACOKINETICS OF MELANOTAN-I IN HUMANS

      Biopharmaceutics & drug disposition
    37. IYENGAR BS; DORR RT; ALBERTS DS; SOLYOM AM; KRUTZSCH M; REMERS WA
      1,4-DISUBSTITUTED ANTHRACENE ANTITUMOR AGENTS

      Journal of medicinal chemistry
    38. SAMI SM; DORR RT; ALBERTS DS; SOLYOM AM; REMERS WA
      1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUENTS AT POSITION-4, POSITION-8, POSITION-9, POSITION-10, AND POSITION-11 - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS (VOL 39, PG 4978, 1996)

      Journal of medicinal chemistry
    39. DORR RT
      SKIN ULCERATION POTENTIAL OF PACLITAXEL IN A MOUSE SKIN MODEL IN-VIVO- REPLY

      Cancer
    40. TRICOT G; ALBERTS DS; JOHNSON C; ROE DJ; DORR RT; BRACY D; VESOLE DH; JAGANNATH S; MEYERS R; BARLOGIE B
      SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY

      Clinical cancer research
    41. DORR RT; LAGEL K; MCLEAN S
      CARDIOPROTECTION OF RAT-HEART MYOCYTES WITH AMIFOSTINE (ETHYOL(R)) AND ITS FREE THIOL, WR-1065, IN-VITRO

      European journal of cancer
    42. PETERSEN EA; GRAYSON JB; HERSH EM; DORR RT; CHIANG SM; OKA M; PROFFITT RT
      LIPOSOMAL AMIKACIN - IMPROVED TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE BEIGE MOUSE MODEL

      Journal of antimicrobial chemotherapy
    43. DORR RT; DVORAKOVA K; SNEAD K; ALBERTS DS; SALMON SE; PETTIT GR
      ANTITUMOR-ACTIVITY OF COMBRETASTATIN-A4 PHOSPHATE, A NATURAL PRODUCT TUBULIN INHIBITOR

      Investigational new drugs
    44. ALBERTS DS; GOLDMAN R; XU MJ; DORR RT; QUINN J; WELCH K; GUILLENRODRIGUEZ J; AICKIN M; PENG YM; LOESCHER L; GENSLER H
      DISPOSITION AND METABOLISM OF TOPICALLY ADMINISTERED ALPHA-TOCOPHEROLACETATE - A COMMON INGREDIENT OF COMMERCIALLY AVAILABLE SUNSCREENS AND COSMETICS

      Nutrition and cancer
    45. DORR RT
      CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES

      Seminars in oncology
    46. DORR RT; LINES R; LEVINE N; BROOKS C; XIANG L; HRUBY VJ; HADLEY ME
      EVALUATION OF MELANOTAN-II, A SUPERPOTENT CYCLIC MELANOTROPIC PEPTIDEIN A PILOT PHASE-I CLINICAL-STUDY

      Life sciences
    47. SAMI SM; DORR RT; SOLYOM AM; ALBERTS DS; IYENGAR BS; REMERS WA
      6-SUBSTITUTED AND 7-SUBSTITUTED 1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES - SYNTHESIS, NUCLEOPHILIC DISPLACEMENTS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    48. SAMI SM; DORR RT; ALBERTS DS; SOLYOM AM; REMERS WA
      1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUENTS AT POSITION-4, POSITION-8, POSITION-9, POSITION-10, AND POSITION-11 - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    49. DORR RT; SNEAD K; LIDDIL JD
      SKIN ULCERATION POTENTIAL OF PACLITAXEL IN A MOUSE SKIN MODEL IN-VIVO

      Cancer
    50. DORR RT; MCLEAN S; ALBERTS DS; SPEICHER L; CAPIZZI RL
      SELECTIVE CARDIOPROTECTION OF RAT-HEART MYOCYTES EXPOSED TO DNA INTERCALATING AGENTS USING AMIFOSTINE (AMI) AND ITS DEPHOSPHORYLATED METABOLITE, WR-1065

      European journal of cancer
    51. DORR RT; BOOL KL
      ANTIDOTE STUDIES OF VINORELBINE-INDUCED SKIN ULCERATION IN THE MOUSE

      Cancer chemotherapy and pharmacology
    52. KINTZEL PE; DORR RT
      ANTICANCER DRUG RENAL TOXICITY AND ELIMINATION - DOSING GUIDELINES FOR ALTERED RENAL-FUNCTION

      Cancer treatment reviews
    53. DORR RT; LIDDIL JD; KLEIN MK; HERSH EM
      PRECLINICAL PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF IMEXON

      Investigational new drugs
    54. SAMI SM; DORR RT; SOLYOM AM; ALBERTS DS; REMERS WA
      AMINO-SUBSTITUTED 1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP

      Journal of medicinal chemistry
    55. KOELLER JM; BURRIS HA; DORR RT; FINLEY RS; GOLDSPIEL BR; KUHN JG; ROWINSKY EK
      PHARMACEUTICAL ISSUES OF PACLITAXEL

      The Annals of pharmacotherapy
    56. PARRISH AR; DORR RT; GANDOLFI AJ; BRENDEL K
      ADULT-RAT MYOCARDIAL SLICES - A TOOL FOR STUDIES OF COMPARATIVE CARDIOTOXICITY

      Toxicology in vitro
    57. DORR RT; LIDDIL JD; IYENGAR BS; LIST AF; REMERS WA
      BIOLOGIC ACTIVITY OF A NUCLEOTIDE CONJUGATE BETWEEN MITOMYCIN-C AND CYTARABINE MONOPHOSPHATE

      Nucleosides & nucleotides
    58. DORR RT; LAUPER D
      DOSING ERROR IN PROTOCOL BOOK

      Journal of clinical oncology
    59. PARANKA NS; DORR RT
      EFFECT OF DOXORUBICIN ON GLUTATHIONE AND GLUTATHIONE-DEPENDENT ENZYMES IN CULTURED RAT-HEART CELLS

      Anticancer research
    60. OGWU SO; BLANCHARD J; NGUYEN LD; HADLEY ME; DORR RT
      A COMPARISON OF HPLC AND BIOASSAY METHODS FOR PLASMA MELANOTAN-II (MT-II) DETERMINATION - APPLICATION TO A PHARMACOKINETIC STUDY IN RATS

      Biopharmaceutics & drug disposition
    61. DORR RT; LAGEL K
      EFFECT OF SULFHYDRYL COMPOUNDS AND GLUTATHIONE DEPLETION ON RAT-HEARTMYOCYTE TOXICITY INDUCED BY 4-HYDROPEROXYCYCLOPHOSPHAMIDE AND ACROLEIN IN-VITRO

      Chemico-biological interactions
    62. TRICOL G; ALBERTS DS; ROE D; DORR RT; VESOLE DH; JAGANNATH S; BARLOGIE B
      HIGH-DOSE MELPHALAN (MEL) AND RENAL-FUNCTION IN MULTIPLE-MYELOMA (MM)

      Blood
    63. JOHNSON PD; DAWSON BV; DORR RT; HADLEY ME; LEVINE N; HRUBY VJ
      COAT COLOR DARKENING IN A DOG IN RESPONSE TO A POTENT MELANOTROPIC PEPTIDE

      American journal of veterinary research
    64. JOHNSON PD; DAWSON BV; DORR RT; HADLEY ME; LEVINE N; HRUBY VJ
      COAT COLOR DARKENING IN A DOG IN RESPONSE TO A POTENT MELANOTROPIC PEPTIDE

      American journal of veterinary research
    65. DORR RT
      CORRECTION TO CANCER-THERAPY PROTOCOLS

      American journal of hospital pharmacy
    66. MEYSKENS FL; SURWIT E; MOON TE; CHILDERS JM; DAVIS JR; DORR RT; JOHNSON CS; ALBERTS DS
      ENHANCEMENT OF REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA-II (MODERATE DYSPLASIA) WITH TOPICALLY APPLIED ALL-TRANS-RETINOIC ACID - A RANDOMIZED TRIAL

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 06:39:59